Back
NovoCure Vs. UniFirst Industry Stock Comparison
Sell
47
NVCR
NovoCure
Last Price:
$28.90
Seasonality Move:
-3.69%
Buy
69
UNF
UniFirst
Last Price:
$214.87
Seasonality Move:
3.95%
Sell
47
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.54 | Buy |
Relative Strength Index (14 RSI): | 53.24 | Buy |
Chaikin Money Flow: | -417586 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
UNF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.68 | Sell |
Relative Strength Index (14 RSI): | 68.31 | Buy |
Chaikin Money Flow: | -720882 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.17 | Sell |
20-day SMA: | 30.62 | Sell |
50-day SMA: | 23.77 | Buy |
200-day SMA: | 19.04 | Buy |
8-day EMA: | 29.94 | Sell |
20-day EMA: | 29.24 | Sell |
50-day EMA: | 25.5 | Buy |
200-day EMA: | 21.37 | Buy |
UNF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 175.89 | Buy |
20-day SMA: | 182.06 | Buy |
50-day SMA: | 189.61 | Buy |
200-day SMA: | 178.52 | Buy |
8-day EMA: | 179.91 | Buy |
20-day EMA: | 182.01 | Buy |
50-day EMA: | 186.63 | Buy |
200-day EMA: | 182.14 | Buy |
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.
UniFirst Earnings Growth & UNF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.98 per share, a decrease this year of $0.14 per share, and an increase next year of $0.92 per share.
NovoCure Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
UniFirst Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |